BAG1: The guardian of anti-apoptotic proteins in acute myeloid leukemia

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Aveic, Sanja ^a   Pigazzi, Martina ^a   Basso, Giuseppe ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 ASSOCIATED ATHANOGENE 1 PROTEIN; BCL2 ASSOCIATED ATHANOGENE 3 PROTEIN; CASPASE 3; CYTOCHROME C; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN USP9X; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAG3 PROTEIN, HUMAN; BCL2-ASSOCIATED ATHANOGENE 1 PROTEIN; DNA BINDING PROTEIN; PROTEASOME; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN THIOLESTERASE; USP9X PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; LOSS OF FUNCTION MUTATION; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; CELL STRAIN HL 60; CHILD; GENETICS; METABOLISM; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; CHILD; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; TRANSCRIPTION FACTORS; UBIQUITIN THIOLESTERASE;

EID: 80053900118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026097     Document Type: Article

References (52)

1. Testa U, Riccioni R, (2007) Deregulation of apoptosis in acute myeloid leukemia. Haematologica 98: 81-94.
2. Tsujimoto Y, (2003) Cell death regulation by the BCL2 protein family in the mitochondria. J Cell Physiol 195: 158-167.
3. Du C, Fang M, Li Y, Li L, Wang X, (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42.
4. Scorrano L, Korsmeyer SJ, (2003) Mechanisms of cytochrome c release by proapoptotic BCL2 family members. Biochem Biophys Res Commun 304: 437-444.
5. Bradbury DA, Russell NH, (1995) Comparative quantitative expression of BCL2 by normal and leukaemic myeloid cells. Br J Haematol 91: 374-379.
6. Campos L, Rouault JP, Sabido O, Oriol P, Vasselon C, et al. (1993) High expression of BCL2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81: 3091-3096.
7. Bensi L, Longo R, Vecchi A, Messora C, Garagnani L, et al. (1995) BCL2 oncoprotein expression in acute myeloid leukemia. Haematologica 80: 98-102.
8. Kaufmann SH, Karp JE, Svingen PA, Krajewski S, Burke PJ, et al. (1998) Elevated expression of the apoptotic regulator MCL1 at the time of leukemic relapse. Blood 91: 991-1000.
9. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, et al. (1995) Cloning and functional analysis of BAG1: a novel BCL2 binding protein with anti-cell death activity. Cell 80: 279-284.
10. Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G, (2003) BAG1: a multi functional regulator of cell growth and survival. Biochim Biophys Acta 1603: 83-89.
11. Doong H, Vrailas A, Kohn EC, (2002) What's in the 'BAG'?-A functional domain analysis of the BAG-family proteins. Cancer Lett 188: 25-32.
12. Townsend PA, Stephanou A, Packham G, Latchman DS, (2005) BAG1: A multi-functional pro-survival molecule. Int J Biochem Cell Biol 37: 251-259.
13. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, et al. (1998) Expression and location of Hsp70/Hsc-Binding anti-apoptotic protein BAG1 and its variants in normal tissues and tumour cell lines. Cancer Res 58: 3116-3131.
14. Packham G, Brimmell M, Cleveland JL, (1997) Mammalian cells express two differently localized BAG1 isoforms generated by alternative translation initiation. Biochem J 328: 807-813.
15. Yang X, Chernenko G, Hao Y, Ding Z, Pater MM, et al. (1998) Human BAG1/Rap46 protein is generated as four isoforms by alternative translation initiation and over-expressed in cancer cells. Oncogene 17: 981-989.
16. Luders J, Demand J, Hohfeld J, (2000) The ubiquitin-related BAG1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem 275: 4613-4617.
17. Hochstrasser M, (1995) Ubiquitin, proteasomes and the regulation of intracellular protein degradation. Curr Opin Cell Biol 7: 215-223.
18. Dou QP, Li B, (1999) Proteasome inhibitors as potential novel anticancer agents. Drug Resist Updates 2: 215-223.
19. Elliott E, Tsvetkov P, Ginzburg I, (2007) BAG-1 associates with Hsc70-Tau complex and regulates proteasomal degradation of Tau protein. J Biol Chem 282: 37276-37284.
20. Takayama S, Xie Z, Reed JC, (1999) An evolutionary conserved family of Hsp70/Hsc70 molecular chaperone regulators. EMBO J 21: 6135-6143.
21. Doong H, Rizzo K, Fang S, Kulpa V, Weissman AM, et al. (2003) CAIR-1/BAG3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol Chem 278: 28490-28500.
22. Lee JH, Takahashi T, Yasuhara N, Inazawa J, Kamada S, et al. (1999) Bis, a BCL2-binding protein that synergizes with BCL2 in preventing cell death. Oncogene 18: 6183-6190.
23. Wang HG, Takayama S, Rapp UR, Reed JC, (1996) BCL2 interacting protein, BAG1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 93: 7063-7068.
24. Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, et al. (1999) High level expression of differentially localized BAG1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer 81: 1042-1051.
25. Kudoh M, Knee DA, Takayama S, Reed JC, (2002) BAG1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells. Cancer res 62: 1904-1909.
26. Rosati A, Ammirante M, Gentilella A, Basile A, Festa M, et al. (2007) Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol 39: 1337-1342.
27. Cutress RI, Townsend PA, Brimmell M, Bateman AC, Hague A, et al. (2002) BAG1 expression and function in human cancer. Br J Cancer 87: 834-839.
28. Bonelli P, Petrella A, Rosati A, Romano MF, Lerose R, et al. (2004) Bag3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 18: 358-360.
29. Gamerdinger M, Hajieva P, Kaya AM, Wolfrum U, Hartl FU, et al. (2009) Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J 28: 889-901.
30. Cammareri P, Scopelliti A, Todaro M, Eterno V, Francescangeli F, et al. (2010) Aurora-A is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells. Cancer Res 70: 4655-4665.
31. Pession A, Rondelli R, Basso G, Rizzari C, Testi AM, et al. (2005) Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. Leukemia 19: 2043-2053.
32. Frascella E, Rondelli R, Pigazzi M, Zampieron C, Fagioli F, et al. (2004) Clinical features of childhood acute myeloid leukaemia with specific gene rearrangements. Leukemia 18: 1427-1429.
33. Ko RH, Ji LY, Barnette P, Bostrom B, Hutchinson R, et al. (2010) Outcome of Pediatric Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study. JCO 28: 648-654.
34. Cheng J, Xiong J, Liu H, Chernenko G, Tang SC, (2002) Distinct BAG1 isoforms have different anti-apoptotic functions in BAG1-transfected C33A human cervical carcinoma cell line. Oncogene 21: 7050-7059.
35. Gotz R, Wiese S, Takayama S, Camarero GC, Rossoll W, et al. (2005) BAG1 is essential for differentiation and survival of hematopoietic and neuronal cells. Nat Neurosci 8: 1169-1178.
36. Konopleva M, Tari AM, Estrov Z, Harris D, Xie Z, et al. (2000) Liposomal BCL2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside and induce apoptosis independent of other anti-apoptotic proteins. Blood 95: 3929-3938.
37. Tsukahara F, Maru Y, (2010) Bag1 directly routes immature BCR-ABL for proteasome degradation. Blood 116: 3582-3592.
38. Maung ZT, MacLean FR, Reid MM, Pearson AD, Proctor SJ, et al. (1994) The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. Br J Haematol 88: 105-109.
39. Konopleva M, Zhao S, Hu W, Jiang S, Snell V, et al. (2002) The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells. Br J Haematol 118: 521-534.
40. Zhou P, Quian L, Kozopas KM, Craig RW, (1997) Mcl-1, a Bcl-2 family member, delays the death of the hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89: 630-643.
41. Anderson LR, Sutherland RL, Butt AJ, (2010) BAG1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation. Oncogene 29: 527-538.
42. Michels J, Johnson PW, Packham G, (2005) MCL1. Int J Biochem Cell Biol 37: 267-271.
43. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM, (1999) Dephosphorylation Tragets BCL2 for Ubiquitin-dependent Degradation: A link between the apoptosome and the proteasome pathway. J Exp Med 189: 1815-1822.
44. Schwickart M, Huang XD, Lill JR, Liu J, Ferrando R, et al. (2010) Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463: 103-108.
45. Sun H, Kapuria V, Peterson LF, Fang D, Bornmann WG, et al. (2011) Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis. Blood 117: 3151-3162.
46. Del Poeta G, Venditti A, Del Principe MI, (2003) Amount of spontaneous apoptosis detected by BAX/BCL2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 101: 2125-2131.
47. Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, et al. (2002) Antisense strategy shows that MCL1 rather than BCL2 or Bcl-XL is an essential survival protein of human myeloma cells. Blood 100: 194-199.
48. Pession A, Rizzari C, Putti MC, Masetti R, Casale F, et al. (2009) Results of the AIEOP AML 2002/01 study for treatment of children with acute myeloid leukemia. Blood 114: 17.
49. Pigazzi M, Manara E, Baron E, Basso G, (2009) miR-34b Targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res 69: 2471-2478.
50. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25: 402-408.
51. Blagosklonny MV, Wu GS, Omura S, el-Deiry WS, (1996) Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem Biophys Res Commun 227: 564-569.
52. Herrant M, Jacquel A, Marchetti S, Belhacene N, Colosetti P, et al. (2004) Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 23: 7863-7873.